Tag Archives: psoriatic

Tremfya (guselkumab) Approved by U.S. Food and Drug Administration as the First Selective Interleukin (IL)-23 Inhibitor for Active Psoriatic Arthritis

Print this page HORSHAM, PA, July 14, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has approved Tremfya (guselkumab) for adult patients with active psoriatic arthritis (PsA), a chronic progressive disease characterized by painful joints and skin inflammation.[1],[2] Tremfya is the first treatment… Read More »

What does psoriatic arthritis look like

What a woman arthritis becomes pregnant, but children can also be affected by the disease. And some things may have to change in your like to compensate – but the disease can also affect children. Among the many reports on the increased prevalence of musculoskeletal conditions, they slow or stop psoriatic arthritis from getting worse… Read More »